Author: GlobeNewswire

In preclinical experiments, icovamenib enhanced beta cell function and responsiveness of human islets to GLP-1-based therapies. These effects were associated…

Cincinnati, OH, Dec. 12, 2024 (GLOBE NEWSWIRE) — Onconetix, Inc. (NASDAQ: ONCO) (the “Company”) announced that it received a letter…

NEEDHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (“Candel”) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused…

No impact at this time on the listing of the Company’s Ordinary Shares on NasdaqCompany intends to submit to Nasdaq…

ADELAIDE, Australia and CAMBRIDGE, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX) (“Bionomics” or the “Company”) is…

Business combination closed November 13, 2024Raised $10 million of gross proceeds in connection with the business combinationAgreements are in place…

Company elects not to advance BBI-825 into Part 2 portion of STARMAP clinical trial Third ecDTx program advancing, with plans…

SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage…

Focus on in vivo CRISPR-edited medicines based on Editas researchers’ recent scientific progress in multiple tissues: Achieved pre-clinical in vivo…